F2G Company
F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
Investors
Total Funding:
£166 346 439
Headquarters:
Manchester, Manchester, United Kingdom
Funding Status:
Venture Capital-Backed
Employee Number:
11-50
Estimated Revenue:
£7 800 000-38 990 000
Last Funding Type:
Venture - Series Unknown
Last Funding Date:
8/12/2020
Investors Number:
18
Founded Date:
1998
Industry:
PharmTech